Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1256]

Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer

Prof Michael Gnant - Medical University of Vienna, Austria

Chemothereapy with endocrine therapy and bisphosphonates in early breast cancer ( Prof Michael Gnant - Medical University of Vienna, Austria )

Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond

Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium

Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond ( Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium )

Non-drug treatments to help alleviate symptoms of treatment-induced menopause

Dr Marc van Beurden - Netherlands Cancer Institute, Amsterdam

Non-drug treatments to help alleviate symptoms of treatment-induced menopause ( Dr Marc van Beurden - Netherlands Cancer Institute, Amsterdam )

Triple negative advanced breast cancer treatment with PARP inhibitors

Dr Tim Yap - Royal Marsden Hospital, London, UK

Triple negative advanced breast cancer treatment with PARP inhibitors ( Dr Tim Yap - Royal Marsden Hospital, London, UK )

Managing the toxicity of aromatase inhibitors

Dr Patrick Neven - Leuven University, Belgium

Managing the toxicity of aromatase inhibitors ( Dr Patrick Neven - Leuven University, Belgium )

Analysis of thirty years of clinical trial data

Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK

Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )

Intraperitoneal therapy: current questions

Prof Franco Muggia – New York University Medical Center, USA

Intraperitoneal therapy: current questions ( Prof Franco Muggia – New York University Medical Center, USA )

PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast...

Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA

PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer ( Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA )

More from ecancer